Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Early Response to Tumor Necrosis Factor Alpha in a Colon Carcinoma Model
Authors:
- 1 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 41 (9) , 691-696
Abstract
Objective: We describe the effects of tumor necrosis factor alpha (TNFα) on tumor microvasculature in a murine colon carcinoma model using serial dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI). Material and Methods: Mice with subcutaneous murine colon carcinomas (MC-38) were imaged at 4.7 T after administration of 0.2 mmol/kg gadolinium-DTPA. Both treated and control mice (each group, n = 4), were scanned at baseline and 2, 4, 6, and 96 hours. A 2-compartment pharmacokinetic model generated parameters such as Ktrans, kep, and initial area under the gadolinium concentration curve (IAUC). Results: The treatment group revealed significant differences in Ktrans at all time points after TNFα. kep and IAUC were significantly reduced at 2, 6, and 96 hours. The coefficient of variation in control animals ranged from 0.13 for IAUC to 0.30 for Ktrans. Mild histologic changes were observed at 2 to 6 hours, but considerable central necrosis with a vascular tumor rim was seen at 96 hours. Conclusion: DCE MRI can be used to detect early effects of TNFα. Serial DCE MRI is a promising tool in assessing the early effects of antivascular therapies.Keywords
This publication has 12 references indexed in Scilit:
- Effect of Tamoxifen in an Experimental Model of Breast Tumor Studied by Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Different Contrast AgentsInvestigative Radiology, 2005
- Imaging Angiogenesis: Applications and Potential for Drug DevelopmentJNCI: Journal of the National Cancer Institute, 2005
- Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsBritish Journal of Radiology, 2003
- Imaging in antiangiogenesis trial: a clinical trials radiology perspectiveBritish Journal of Radiology, 2003
- MRI for assessing antivascular cancer treatmentsBritish Journal of Radiology, 2003
- Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imagingJournal of Magnetic Resonance Imaging, 2003
- Dynamic T1‐weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imagingInternational Journal of Cancer, 2003
- Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directionsJournal of Magnetic Resonance Imaging, 2002
- Tumor Microvascular Changes to Anti-Angiogenic Treatment Assessed by MR Contrast Media of Different Molecular WeightsAcademic Radiology, 2002
- Functional and molecular MR imaging of angiogenesis: Seeing the target, seeing it workJournal of Cellular Biochemistry, 2002